SavedAdd your journal

Journals / Eurasian Journal of Medicine / 2011 / Cilt: 43 - Sayı: 3

Behçet hastalarında aso düzeyleri

Antistreptolysin o levels in patients with behcet’s disease

Hülya UZKESER
Saliha KARATAY
ALİ KARAKUZU
Kadir YILDIRIM
Muhammed Hamidullah UYANIK
Pages
169–172
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the patients with Behcet’s disease, ASO (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Behcet’s disease is a multisystem inflammatory disorder, and its etiology has not been defined clearly yet.
📊
Key Findings & Data:Materials and Methods: Thirty patients with Behcet’s disease and 30 healthy controls were enrolled in this study.
💡
Conclusion & Impact:In the patients with Behcet’s disease, ASO (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Behcet’s disease is a multisystem inflammatory disorder, and its etiology has not been defined clearly yet. In this study, we aimed to investigate the antistreptolysin O (ASO) levels of patients with Behcet’s disease. Materials and Methods: Thirty patients with Behcet’s disease and 30 healthy controls were enrolled in this study. We measured erythrocyte sedimentation rate (ESR), serum C-reactive protein (CRP), and ASO levels in both groups. Results: There was no statistically significant difference between the two groups with respect to demographic data (p>0.05). The ASO levels of the patients and the controls were 288.4±145.7 and 170.6±142.4 ng/ml, respectively. In the patients with Behcet’s disease, ASO (p

Özet

Amaç: Behçet hastalığı multisistemik inflamatuar bir hastalıktır. Behçet hastalığının etiyolojisi henüz tam olarak belirlenememiştir. Bu çalışmada Behçet hastalarında antistreptolizin O (ASO) düzeylerinin incelenmesi amaçlanmıştır. Gereç ve Yöntem: Bu çalışmaya 30 Behçet hastası ve 30 sağlıklı kontrol katıldı. Her iki grupta eritrosit sedimantasyon hızı (ESH), serum C-reaktif protein (CRP) ve ASO düzeyleri ölçüldü. Bulgular: İki grup arasında demografik veriler açısından istatistiksel olarak anlamlı bir fark yoktu (p>0.05). Hasta ve kontrollerin ASO düzeyleri sırasıyla 288.4±145.7 ve 170.6±142.4 ng/ml idi. Behçet hastalarında ASO (p

🔖

Cite This Article

UZKESER, H., KARATAY, S., KARAKUZU, A., YILDIRIM, K., UYANIK, M. H. (2022). Behçet hastalarında aso düzeyleri. Eurasian Journal of Medicine, Cilt: 43 - Sayı: 3, 169–172. https://ajindex.com/articles/509274

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Erdem F. MEFV Gene mutations in Behçet’s disease. EAJM 2007; 39: 130-3
  2. Kastner DL. Intermittent and periodic arthritic syndromes. In: Kopman WJ, ed. Arthritis and allied conditions: a textbook of rheumatology. 13th ed. Vol
  3. Baltimore: Williams&Wilkins 1997: pp. 1279-306
  4. Melikoglu MA, Melikoglu M. The influence of age on Behcet’s disease activity. EAJM 2008; 40: 68-71
  5. Ghate JV, Jorizzo JL. Behçet’s disease and complex aphthosis. J Am Acad Dermatol 1999; 40: 1-18
  6. Zierhut M, Mizuki N, Ohno S, et al. Immunology and functional genomics of Behçet’s disease. Cell Mol Life Sci 2003; 60: 1903-22
  7. Mizushima Y. Behcet’s disease. Curr Opin Rheumatol 1991; 3: 32-5
  8. Tsuchida M, Mineshita S, Okonogi H, et al. The role of an uncommon type of oral streptococcus sanguis in the etiology of behcet’s disease. Environ Health Prev Med 1997; 2: 59-63
  9. Isogai E, Ohno S, Kotake S, et al. Chemiluminescence of neutrophils from patients with Behçet’s disease and its correlation with an increased proportion of uncommon serotypes of Streptococcus sanguis in the oral flora. Arch Oral Biol 1990; 35: 43-8
  10. Hilário MO, Terreri MT. Rheumatic fever and post-streptococcal arthritis. Best Pract Res Clin Rheumatol 2002; 16: 481-94
  11. Hahn RG, Knox LM, Forman TA. Evaluation of poststreptococcal illness. Am Fam Physician 2005; 71: 1949-54
  12. International Study Group for Behçet’s Disease Criteria for diagnosis of Behçet’s disease. Lancet 1990; 335: 1078-80
  13. Evereklioglu C, Ozbek E, Cekmen M, et al. Plasma malondialdehyde levels in Behcet’s disease with or without ocular involvement. Adv Reprod 2000; 4: 231-6
  14. Calamia KT, Schirmer M, Melikoglu M. Major vessel involvement in Behçet’s disease: an update. Curr Opin Rheumatol 2011; 23: 24-31
  15. Oztas MO, Onder M, Gurer MA, Bukan N, Sancak B. Serum interleukin 18 and tumour necrosis factor-α levels are increased in Behçet’s disease. Clin Exp Dermatol 2005; 30: 61-3
  16. Oh SH, Lee KY, Lee JH, Bang D. Clinical manifestations associated with high titer of anti-streptolysin O in Behcet’s disease. Clin Rheumatol 2008; 27: 999-1003
  17. Kaneko F, Oyama N, Nishibu A. Streptococcal infection in the pathogenesis of Behçet’s disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J 1997; 38: 444-54
  18. Hirohata S, Oka H, Mizushima Y. Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet’s disease. Cell Immunol 1992; 140: 410-9.